IGBA nominated David Gaugh, AAM's Interim CEO, as the new IGBA Chair for 2023 (April 2023)
IGBA informs that Jonathan Kimball is no longer part of the staff of the Association for Accessible Medicines (AAM), our U.S. IGBA Member, and hence, is no longer in the position as IGBA Chair. Subsequently, David Gaugh, AAM's Interim CEO, has taken up the Director role for AAM on the IGBA Management Committee. To ensure continuity, IGBA is very pleased to announce that the IGBA Management Committee has unanimously nominated David Gaugh as the new IGBA Chair for the rest of 2023. David has been involved within IGBA since 2012, and was previously the IGBA Chair in 2014, where he lead the then Alliance to be legalized under Swiss law to become the Association. David again chaired the IGBA in 2018.